Magnetic Resonance Spectrobiopsy for Prediction of Isocitrate Dehydrogenase Mutation in Glioma

被引：3
|
作者：
Grasso, Giovanni [1 ]
Torregrossa, Fabio [1 ]
机构：
[1] Univ Palermo, Dept Biomed Neurosci & Adv Diagnost BiND, Sect Neurosurg, Palermo, Italy
来源：
WORLD NEUROSURGERY | 2020年 / 134卷
关键词：
2HG; 2-Hydroxyglutarate; Glioma; Magnetic resonance spectroscopy; MRS; Neuroimaging; GLIOBLASTOMA-MULTIFORME; RESECTION; EXTENT; BRAIN; 2-HYDROXYGLUTARATE; ERYTHROPOIETIN; SPECTROSCOPY; INHIBITOR; DISEASE;
D O I：
10.1016/j.wneu.2019.10.181
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：187 / 189
页数：3
相关论文
共 50 条
  • [31] The Correlation of In Vivo MR Spectroscopy and Ex Vivo 2-Hydroxyglutarate Concentration for the Prediction of Isocitrate Dehydrogenase Mutation Status in Diffuse Glioma
    van Dijken, Bart R. J.
    Jeltema, Hanne-Rinck
    Klos, Justyna
    van Laar, Peter Jan
    Enting, Roelien H.
    Maatman, Ronald G. H. J.
    Bijsterveld, Klaas
    Den Dunnen, Wilfred F. A.
    Dierckx, Rudi A.
    Sijens, Paul E.
    van der Hoorn, Anouk
    DIAGNOSTICS, 2023, 13 (17)
  • [32] Isocitrate Dehydrogenase-Mutant Glioma: Evolving Clinical and Therapeutic Implications
    Miller, Julie J.
    Shih, Helen A.
    Andronesi, Ovidiu C.
    Cahill, Daniel P.
    CANCER, 2017, 123 (23) : 4535 - 4546
  • [33] Isocitrate Dehydrogenase Mutations in Glioma: From Basic Discovery to Therapeutics Development
    Huang, Juan
    Yu, Jialong
    Tu, Lin
    Huang, Nanqu
    Li, Hang
    Luo, Yong
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [34] Advances in the Immunotherapeutic Potential of Isocitrate Dehydrogenase Mutations in Glioma
    Feng Tang
    Zhiyong Pan
    Yi Wang
    Tian Lan
    Mengyue Wang
    Fengping Li
    Wei Quan
    Zhenyuan Liu
    Zefen Wang
    Zhiqiang Li
    Neuroscience Bulletin, 2022, 38 : 1069 - 1084
  • [35] Advances in the Immunotherapeutic Potential of Isocitrate Dehydrogenase Mutations in Glioma
    Tang, Feng
    Pan, Zhiyong
    Wang, Yi
    Lan, Tian
    Wang, Mengyue
    Li, Fengping
    Quan, Wei
    Liu, Zhenyuan
    Wang, Zefen
    Li, Zhiqiang
    NEUROSCIENCE BULLETIN, 2022, 38 (09) : 1069 - 1084
  • [36] Rapid detection of mutation in isocitrate dehydrogenase 1 and 2 genes using mass spectrometry
    Kanamori, Masayuki
    Maekawa, Masamitsu
    Shibahara, Ichiyo
    Saito, Ryuta
    Chonan, Masashi
    Shimada, Miki
    Sonoda, Yukihiko
    Kumabe, Toshihiro
    Watanabe, Mika
    Mano, Nariyasu
    Tominaga, Teiji
    BRAIN TUMOR PATHOLOGY, 2018, 35 (02) : 90 - 96
  • [37] Identification of the Prognostic Signatures for Isocitrate Dehydrogenase Mutant Glioma
    Mamatjan, Yasin
    Voisin, Mathew
    Nassiri, Farshad
    Salih, Mira
    Moraes, Fabio Y.
    Bunda, Severa
    Tursun, Risalet
    von Deimling, Andreas
    Aldape, Kenneth D.
    Zadeh, Gelareh
    2022 IEEE CONFERENCE ON COMPUTATIONAL INTELLIGENCE IN BIOINFORMATICS AND COMPUTATIONAL BIOLOGY (IEEE CIBCB 2022), 2022, : 83 - 89
  • [38] Functional reorganization of contralesional networks varies according to isocitrate dehydrogenase 1 mutation status in patients with left frontal lobe glioma
    Qi, Chong
    Wang, Rui
    Meng, Lanxi
    Li, Shaowu
    Li, Yiming
    NEURORADIOLOGY, 2022, 64 (09) : 1819 - 1828
  • [39] Predicting Isocitrate Dehydrogenase Mutation Status in Glioma Using Structural Brain Networks and Graph Neural Networks
    Wei, Yiran
    Li, Yonghao
    Chen, Xi
    Schonlieb, Carola-Bibiane
    Li, Chao
    Price, Stephen J.
    BRAINLESION: GLIOMA, MULTIPLE SCLEROSIS, STROKE AND TRAUMATIC BRAIN INJURIES, BRAINLES 2021, PT I, 2022, 12962 : 140 - 150
  • [40] Microfluidics for rapid detection of isocitrate dehydrogenase 1 mutation for intraoperative application
    Aibaidula, Abudumijiti
    Zhao, Wang
    Wu, Jin-song
    Chen, Hong
    Shi, Zhi-feng
    Zheng, Lu-lu
    Mao, Ying
    Zhou, Liang-fu
    Sui, Guo-dong
    JOURNAL OF NEUROSURGERY, 2016, 124 (06) : 1611 - 1618
12345